The size of the Optogenetics Market in Europe was worth USD 4.37 billion in 2019 and estimated to reach $ 9.34 billion by the end of 202u4 with a CAGR of 16.40%.
Growing support from the government and non-government organizations is a key driving factor for the market to grow. The rise in the number of people suffering from various psychiatrist disorders is escalating the demand of the market. Introduction of new methods in neuroscience technology where optogenetics technology plays a crucial role to cure psychiatrist disorders like depression, addiction, and other disorders is propelling the demand of the market to the extent. Increasing incidences of neurological problems across the region are accelerating the growth rate of the optogenetics market. Also, awareness of the availability of different treatment procedures among individuals is expanding the demand of the market.
However, lack of skilled professionals in monitoring and analyzing the reports especially in undeveloped countries is slowly restraining the demand of the market. Cost for installation and maintenance of the equipment need huge amounts which are impossible for the small scale enterprises and this is degrading the growth rate of the Europe optogenetics market. Frequent changes in the economic strategies by the government have remained as a challenging factor for the market players. Besides, rising complications after the treatment procedures in a few people are inhibiting the demand of the market.
Increasing investments in the development of infrastructure in hospitals and clinics are certainly to create growth opportunities for the market. Also, creating popularity through campaigns and digital advertisement is likely to bolster the growth rate of the Europe optogenetics market. Pharmaceutical companies are developing innovative products in favor of the end-users where this is ascribed to boost up the demand of the market. Rising research centers in order to develop novel drug targets are enhancing the growth rate of the optogenetics market in Europe. Increasing disposable income in urban areas is leveling up the demand of the market. The emergence of the latest technology in the medical sector is additionally elevating the growth rate of the optogenetics market.
This research report has been segmented & sub-segmented into the following categories:
Regionally, Europe comes second in terms of region-wise revenue following North America in the Global market.
Prominent companies in the Europe Optogenetics Market profiled in this report are Coherent Inc., Noldus, Thorlabs Inc. Cobalt Inc., Scientifica, Bruker, Laserglow technologies, Regenxbio Inc., Gensight, Addgene, UPenn Vector Core and Jackson Laboratories.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Sensor Type
5.1.1 Genetically Encoded Calcium Indicators
5.1.2 pH Sensors
5.1.3 Neurotransmitter Release
5.1.4 Voltage-Sensitive Fluorescent Proteins
5.2 By Technique
5.2.1 Archaerhodopsin
5.2.2 Channelrhodopsin
5.2.3 Halorhodopsin
5.3 By Application
5.3.1 Retinal Disease Treatment
5.3.2 Cardioversion
5.3.3 Neuroscience
5.3.4 Behavioral Tracking
5.3.5 Pacing
5.4 By Light Equipment
5.4.1 Lasers
5.4.2 LEDs
5.4.3 Others
6. Geographical Analysis
6.1 Introduction
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Coherent Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Noldus
8.3 Thorlabs Inc.
8.4 Cobalt Inc.
8.5 Scientifica
8.6 Bruker
8.7 Laserglow Technologies
8.8 Regenxbio Inc.
8.9 Gensight
8.10 Addgene
8.11 UPenn Vector Core
8.12 Jackson Laboratories
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
